177 related articles for article (PubMed ID: 23826570)
41. CD103-CD23+ classical hair cell leukemia: A case report and review of the literature.
Zhao HL; Cui HH; Jin LF; Zhao M; Shen WZ
Medicine (Baltimore); 2021 Dec; 100(51):e28262. PubMed ID: 34941102
[TBL] [Abstract][Full Text] [Related]
42. BRAF mutations in hairy-cell leukemia.
Takahashi Y; Mori J; Kami M
N Engl J Med; 2011 Sep; 365(10):960-1; author reply 961-2. PubMed ID: 21899463
[No Abstract] [Full Text] [Related]
43. Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
Paillassa J; Maitre E; Troussard X
Curr Oncol Rep; 2022 Sep; 24(9):1133-1143. PubMed ID: 35403971
[TBL] [Abstract][Full Text] [Related]
44. BRAF V600E mutation-specific antibody, a sensitive diagnostic marker revealing minimal residual disease in hairy cell leukaemia.
Akarca AU; Shende VH; Ramsay AD; Diss T; Pane-Foix M; Rizvi H; Calaminici MR; Grogan TM; Linch D; Marafioti T
Br J Haematol; 2013 Sep; 162(6):848-51. PubMed ID: 23848818
[No Abstract] [Full Text] [Related]
45. Exceptions to the rule in hairy cell leukaemia: implications for molecular diagnostics and targeted therapy.
Langabeer SE
Med Oncol; 2014 Apr; 31(4):895. PubMed ID: 24557587
[No Abstract] [Full Text] [Related]
46. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
Else M; Dearden CE; Catovsky D
Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
[TBL] [Abstract][Full Text] [Related]
47. Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib.
Vergote V; Dierickx D; Janssens A; Verhoef G; Tousseyn T; Vandenberghe P; Wolter P; Delforge M
Ann Hematol; 2014 Dec; 93(12):2087-9. PubMed ID: 24863690
[No Abstract] [Full Text] [Related]
48. BRAF inhibitor therapy in HCL.
Dietrich S; Zenz T
Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
[TBL] [Abstract][Full Text] [Related]
49. BRAF V600E and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone lymphoma cases.
Shin SY; Lee ST; Kim HJ; Ki CS; Jung CW; Kim JW; Kim SH
Ann Lab Med; 2015 Mar; 35(2):257-9. PubMed ID: 25729732
[No Abstract] [Full Text] [Related]
50. Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib.
Follows GA; Sims H; Bloxham DM; Zenz T; Hopper MA; Liu H; Bench A; Wright P; Van't Veer MB; Scott MA
Br J Haematol; 2013 Apr; 161(1):150-3. PubMed ID: 23278307
[No Abstract] [Full Text] [Related]
51. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing.
Vacca D; Cancila V; Gulino A; Lo Bosco G; Belmonte B; Di Napoli A; Florena AM; Tripodo C; Arancio W
Mol Biol Rep; 2018 Feb; 45(1):1-7. PubMed ID: 29238890
[TBL] [Abstract][Full Text] [Related]
52. Detection of an IGH-
Thompson ER; Lim KJC; Kuzich JA; McBean M; Westerman D; Tam CS; Blombery P
Leuk Lymphoma; 2020 Aug; 61(8):2024-2026. PubMed ID: 32319330
[No Abstract] [Full Text] [Related]
53. The BRAF-V600E mutation in hematological malignancies: a new player in hairy cell leukemia and Langerhans cell histiocytosis.
Tadmor T; Tiacci E; Falini B; Polliack A
Leuk Lymphoma; 2012 Dec; 53(12):2339-40. PubMed ID: 22738431
[No Abstract] [Full Text] [Related]
54. A case of concomitant chronic lymphocytic leukaemia and hairy cell leukaemia evaluated for IGHV-D-J rearrangements and BRAF-V600E mutation: lack of evidence for a common origin.
Cavalli M; Ilari C; Del Giudice I; Marinelli M; Della Starza I; De Propris MS; De Novi LA; Nunes V; Cafforio L; Raponi S; Mancini F; Mauro FR; Tiacci E; Falini B; Guarini A; Foà R
Br J Haematol; 2016 Jul; 174(2):329-31. PubMed ID: 26455504
[No Abstract] [Full Text] [Related]
55. The Biology of Classic Hairy Cell Leukemia.
Bohn JP; Salcher S; Pircher A; Untergasser G; Wolf D
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360545
[TBL] [Abstract][Full Text] [Related]
56. A patient diagnosed with BRAF-mutated non-small cell lung cancer and hairy cell leukemia: at last, which entity is really carrying the BRAF mutation?
Schlick K; Troch M; Placher-Sorko G; Faber V; Neureiter D; Berghoff AS; Preusser M; Greil R; Hopfinger G
Ann Hematol; 2015 Feb; 94(2):345-6. PubMed ID: 25055797
[No Abstract] [Full Text] [Related]
57. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
Wierda WG; Byrd JC; Abramson JS; Bhat S; Bociek G; Brander D; Brown J; Chanan-Khan A; Coutre SE; Davis RS; Fletcher CD; Hill B; Kahl BS; Kamdar M; Kaplan LD; Khan N; Kipps TJ; Lancet J; Ma S; Malek S; Mosse C; Shadman M; Siddiqi T; Stephens D; Wagner N; Zelenetz AD; Dwyer MA; Sundar H
J Natl Compr Canc Netw; 2017 Nov; 15(11):1414-1427. PubMed ID: 29118233
[TBL] [Abstract][Full Text] [Related]
58. BRAF mutation detection in hairy cell leukaemia from archival haematolymphoid specimens.
Thomas C; Amanuel B; Finlayson J; Grieu-Iacopetta F; Spagnolo DV; Erber WN
Pathology; 2015 Jun; 47(4):349-54. PubMed ID: 25938346
[TBL] [Abstract][Full Text] [Related]
59. Identification of the BRAF V600E mutation in Japanese patients with hairy cell leukemia and related diseases using a quenching probe method.
Itamura H; Ide M; Sato A; Sueoka-Aragane N; Sueoka E; Nishida A; Masunari T; Aoki S; Takizawa J; Suzumiya J; Kimura S
Int J Hematol; 2018 Oct; 108(4):416-422. PubMed ID: 30043333
[TBL] [Abstract][Full Text] [Related]
60. Absence of BRAF V600E mutation in hematologic malignancies excluding hairy-cell leukemia.
Ping N; Wang Q; Wang Q; Dong S; Wu L; Xue Y; Ruan C; Wu D; Chen S
Leuk Lymphoma; 2012 Dec; 53(12):2498-9. PubMed ID: 22639828
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
